Bellevue Life Sciences Acquisition Corp. (BLAC) Ownership

$1.40

$0.23 (-14.11%)
Last update: 04:00 PM EST
Day's range
$1.38
Day's range
$1.55

Bellevue Life Sciences Acquisition Corp. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 105 $1.20 K   0.00% 0.00%
UBS GROUP AG 02/14/2025 5 $56   -97.72% 0.00%
BERKLEY W R CORP 02/14/2025 0 $0   -100.00% 0.00%
AQR ARBITRAGE LLC 02/14/2025 0 $0   -100.00% 0.00%
WOLVERINE ASSET MANAGEMENT LLC 02/03/2025 0 $0   -100.00% 0.00%
WALLEYE TRADING LLC 02/13/2025 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 0 $0   -100.00% 0.00%
RIVERNORTH CAPITAL MANAGEMENT, LLC 02/14/2025 0 $0   -100.00% 0.00%
WARBERG ASSET MANAGEMENT LLC 02/13/2025 0 $0   -100.00% 0.00%
WALLEYE CAPITAL LLC 02/13/2025 0 $0   -100.00% 0.00%
QUARRY LP 02/14/2025 0 $0   -100.00% 0.00%

Bellevue Life Sciences Acquisition Corp. institutional Ownership - FAQ's

During the previous two years, 4 institutional investors and hedge funds held shares of Bellevue Life Sciences Acquisition Corp.. The most heavily invested institutionals were:

UBS Group AG: 0

Tower Research Capital LLC (TRC): 0

COWEN AND COMPANY, LLC: 185,761

Exos TFP Holdings LLC: 200,000

0.35% of Bellevue Life Sciences Acquisition Corp. stock is owned by institutional investors.

Institutional investors have bought a total of 385.76 K shares in the last 24 months. This purchase volume represents approximately $540.07 K in transactions.